{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
KMC Speciality Hospitals (India) Ltd
Why is KMC Speciality falling/rising?
On 24-Nov, KMC Speciality Hospitals (India) Ltd witnessed a notable decline in its share price, falling by 4.27% to close at ₹74.20. This drop reflects a continuation of recent downward momentum, with the stock underperforming both its sector and broader market indices.
KMC Speciality Hospitals (India) Sees Mixed Technical Signals Amid Price Momentum Shift
KMC Speciality Hospitals (India) has experienced a nuanced shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. The stock’s recent price momentum and technical indicators such as MACD, RSI, and moving averages reveal a landscape that demands careful analysis for investors tracking this hospital sector player.
KMC Speciality Hospitals Reports Strong Financial Metrics and Operational Effectiveness
KMC Speciality Hospitals has reported notable financial improvements for the quarter ending September 2025, with record net sales of Rs 74.90 crore and a profit before tax of Rs 13.50 crore. The company maintains a low debt-equity ratio of 0.47, reflecting stability and effective management.
KMC Speciality Hospitals Q2 FY26: Robust Growth Momentum Continues Despite Margin Pressures
KMC Speciality Hospitals (India) Ltd., the Tiruchirappalli-based healthcare provider, reported a standout performance for Q2 FY26, with net profit surging 43.81% quarter-on-quarter to ₹10.84 crores from ₹7.54 crores in Q1 FY26. On a year-on-year basis, profitability more than doubled, registering a remarkable 179.38% increase from ₹3.88 crores in Q2 FY25. The company's shares responded positively, advancing 2.06% to ₹79.75 on November 14, 2025, as investors digested the strong operational performance that underscored the hospital chain's expanding footprint in southern India.
Is KMC Speciality overvalued or undervalued?
As of November 13, 2025, KMC Speciality is considered undervalued with a PE Ratio of 41.88 and an attractive valuation compared to peers like Apollo Hospitals and Max Healthcare, while also outperforming the Sensex with a 1-week return of 12.88%.
How has been the historical performance of KMC Speciality?
KMC Speciality has shown steady growth in net sales and total operating income, reaching 231.60 Cr in March 2025, but faced declines in profit metrics and increased liabilities, indicating potential profitability challenges. Cash flow from operations improved, contributing to a stronger cash position despite negative investing cash flow.
Is KMC Speciality overvalued or undervalued?
As of November 12, 2025, KMC Speciality's valuation has shifted from attractive to fair, with a PE ratio of 54.51, indicating that while it has outperformed the market with a 302.98% return over five years, investors should exercise caution due to its high valuation compared to peers.
KMC Speciality Hospitals Adjusts Valuation Amidst Mixed Industry Performance Trends
KMC Speciality Hospitals has recently adjusted its valuation, with its stock price reflecting a significant increase. Over the past year, the company has faced challenges, underperforming compared to the Sensex. Key financial metrics indicate operational efficiency, while comparisons with peers reveal diverse performance within the hospital industry.
How has been the historical performance of KMC Speciality?
KMC Speciality has shown consistent growth in net sales, increasing from INR 96.18 crore in March 2020 to INR 231.60 crore in March 2025, despite fluctuations in profitability and rising liabilities. Operating profit reached INR 59.98 crore in March 2025, while total debt rose significantly during the same period.
Why is KMC Speciality falling/rising?
As of 12-Nov, KMC Speciality Hospitals (India) Ltd is currently priced at Rs 78.38, reflecting a 7.72% increase and strong performance with a 13.79% return over the past week, significantly outperforming the Sensex. The stock's bullish trend is supported by rising delivery volume and consistent gains over the last five days.
KMC Speciality Hospitals Shows Improved Financial Health Amid Market Challenges
KMC Speciality Hospitals has experienced a recent evaluation adjustment, reflecting a shift in market sentiment. The company showcases strong financial health with a low Debt to EBITDA ratio and a significant operating profit to interest ratio. Despite a challenging year, net sales and profit after tax have shown notable growth.
KMC Speciality Hospitals Shows Mixed Technical Trends Amid Market Volatility
KMC Speciality Hospitals has recently revised its market evaluation, with its stock showing notable volatility over the past year. Technical indicators present mixed signals, while KMC's performance reflects a marginal weekly gain and a significant five-year growth, contrasting with its year-to-date performance against the Sensex.
How has been the historical performance of KMC Speciality?
KMC Speciality has shown significant growth in net sales, reaching 231.60 Cr in Mar'25, despite a decline in profitability with profit after tax falling to 21.43 Cr. Total expenditure increased to 174.71 Cr, while cash flow from operating activities improved to 57.00 Cr, indicating a positive cash position.
KMC Speciality Hospitals Forms Golden Cross, Signals Potential Bullish Breakout
KMC Speciality Hospitals has recently experienced a Golden Cross, indicating potential upward momentum in its stock price. Despite a year-to-date decline of 8.38%, the stock's technical indicators suggest a mildly bullish outlook. The company operates in the hospital industry with a market size of Rs 1,142.00 Cr.
Why is KMC Speciality falling/rising?
As of 13-Oct, KMC Speciality Hospitals (India) Ltd's stock price is Rs 70.15, down 1.49%, and has fallen 7.17% over the last three days. The stock has underperformed the benchmark significantly, with a year-to-date decline of 8.71% compared to the Sensex's 5.36% increase.
Is KMC Speciality overvalued or undervalued?
As of October 9, 2025, KMC Speciality is considered undervalued with an attractive valuation grade, a PE ratio of 50.80, and strong long-term growth potential, especially compared to its peers like Max Healthcare and Apollo Hospitals, despite a recent decline in stock performance.
Is KMC Speciality overvalued or undervalued?
As of October 8, 2025, KMC Speciality is fairly valued with a PE ratio of 52.54 and has recently outperformed the Sensex, but its year-to-date return of -1.68% indicates potential challenges ahead.
KMC Speciality Hospitals Adjusts Valuation Amidst Competitive Market Landscape
KMC Speciality Hospitals has recently adjusted its valuation, with its stock price at 75.55. Over the past year, it has seen a return of -8.87%, contrasting with the Sensex's modest gain. Notably, KMC achieved a 263.22% return over five years, reflecting its long-term performance in the hospital sector.
Why is KMC Speciality falling/rising?
As of 06-Oct, KMC Speciality Hospitals (India) Ltd is seeing a price increase to Rs 74.01, up 9.69%, with strong performance and positive trading trends, including a significant rise in delivery volume. Despite a year-to-date decline, recent gains indicate growing investor optimism.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
